Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2009.10.013DOI Listing

Publication Analysis

Top Keywords

thrombophilic gene
4
gene variants
4
thrombophilic
1
variants
1

Similar Publications

Background: Clinical expressivity of the thrombophilic factor V Leiden (FVL) mutation is highly variable. Recently, we demonstrated an increased APC (activated protein C) response in asymptomatic FVL carriers compared with FVL carriers with a history of venous thromboembolism (VTE) after in vivo coagulation activation. Here, we further explored this association using a recently developed ex vivo model based on patient-specific endothelial colony-forming cells (ECFCs).

View Article and Find Full Text PDF

Unlabelled: Inherited antithrombin deficiency is an autosomal dominant thrombophilia, resulting from genetic variations in the serpin family C member 1 (SERPINC1) gene. Antithrombin deficiency increases the risk of venous thromboembolism (VTE) compared to the general population. In this report, a novel missense variant of , c.

View Article and Find Full Text PDF
Article Synopsis
  • - Multifocal osteonecrosis is a rare condition that can cause significant bone weakness and fractures, highlighted in a case of a 34-year-old woman whose symptoms worsened during pregnancy.
  • - Investigations revealed the patient had an undefined autoimmune condition and low Protein S levels, along with a novel genetic variant related to Protein S deficiency.
  • - The combination of inherited thrombophilia, autoimmune issues, and pregnancy-related changes contributed to the patient's severe symptoms, with her genetic variant potentially explaining the link between autoimmunity and thrombophilia.
View Article and Find Full Text PDF

Combined deficiency of coagulation factor V (FV) and factor VIII (FVIII) is a rare bleeding disease caused by variants in either lectin mannose binding 1 (LMAN1) or multiple coagulation factor deficiency 2 (MCFD2) gene. Reducing the level of FVIII by inhibiting the LMAN1-MCFD2 complex may become a new anticoagulant approach. We aimed to find a new therapeutic option for anticoagulation by RNA interference (RNAi) targeting LMAN1 and MCFD2.

View Article and Find Full Text PDF

Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) and venous thromboembolism (VTE) are thought to share many common risk factors. Our study aimed to determine the frequencies of 5 thrombosis-related gene single nucleotide polymorphisms (SNPs) associated with VTE in patients with CTEPH (n 129) compared with a control group of healthy individuals without a history of VTE (n 2637).

Methods: The SNPs of the following genes were investigated: (F V Leiden, rs6025), prothrombin (rs1799963), fibrinogen gamma (FGG, rs2066865), (rs2289252) and (non-O, rs8176719) in both groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!